- Latest week
- 10 Jul 2026
- Close
- 23.350000
- Fair value
- 64.389057
- Next-week expectancy
- Negative 42.32%
EQL Chart Pack
EQL Pharma AB
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, EQL fell 53.94%, moving from 50.70 to 23.35. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -63.03 and has softened across the 12-week window. Market Dynamics is -1.10 on the latest week. Next-week expectancy is negative at 42.32% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 23.35
- 12-Week Change
- -53.94%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 42.32%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -63.03
- Market Dynamics
- -1.10
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 23.35
- 12-Week Change
- -53.94%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 42.32%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -63.03
- Market Dynamics
- -1.10
Over the latest 12 completed weeks ending 2026-07-10, EQL fell 53.94%, moving from 50.70 to 23.35. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -63.03 and has softened across the 12-week window. Market Dynamics is -1.10 on the latest week. Next-week expectancy is negative at 42.32% based on similar historical setup states.
Industry Peers
Sweden equities in Drug Manufacturers - Specialty & Generic
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| NEWBRY Newbury Pharmaceuticals AB (publ) | STO | 10 Jul 2026 | 2.06 | 2.50 | 1.22 | 2.42 | 17.48% |
| ENZY Enzymatica AB (publ) | STO | 10 Jul 2026 | 2.27 | 2.60 | 2.21 | 2.48 | 9.25% |
| CINPHA Cinclus Pharma Holding AB (publ) | STO | 10 Jul 2026 | 11.28 | 12.20 | 11.18 | 11.98 | 6.21% |
| NANEXA Nanexa AB (publ) | STO | 10 Jul 2026 | 3.57 | 3.73 | 3.53 | 3.70 | 3.64% |
| ACUC AcuCort AB | STO | 10 Jul 2026 | 0.62 | 0.67 | 0.60 | 0.64 | 3.23% |
| MOB Moberg Pharma AB (publ) | STO | 10 Jul 2026 | 9.45 | 9.73 | 9.23 | 9.47 | 0.21% |
| PMED PEPTONIC Medical AB | STO | 10 Jul 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| VIVE Vivesto AB | STO | 10 Jul 2026 | 8.50 | 9.18 | 8.10 | 8.45 | -0.59% |
| SOBI Swedish Orphan Biovitrum AB (publ) | STO | 10 Jul 2026 | 480.00 | 487.00 | 470.60 | 471.20 | -1.83% |
| KLAR Klaria Pharma Holding AB (publ.) | STO | 10 Jul 2026 | 0.78 | 0.85 | 0.74 | 0.76 | -2.31% |
| BIOG-B BioGaia AB (publ) | STO | 10 Jul 2026 | 120.20 | 121.50 | 116.50 | 116.50 | -3.08% |
| ORX Orexo AB (publ) | STO | 10 Jul 2026 | 24.40 | 25.35 | 22.50 | 23.20 | -4.92% |
| CRNO-B Cereno Scientific AB (publ) | STO | 10 Jul 2026 | 5.13 | 5.21 | 4.70 | 4.83 | -5.93% |
| ALVO-SDB Alvotech SDB | STO | 10 Jul 2026 | 35.80 | 36.45 | 32.30 | 33.55 | -6.28% |
| DICOT Dicot Pharma AB | STO | 10 Jul 2026 | 0.21 | 0.21 | 0.18 | 0.19 | -7.16% |
| ODI ODI Pharma AB | STO | 10 Jul 2026 | 2.56 | 3.00 | 2.12 | 2.30 | -10.16% |